vs
Side-by-side financial comparison of DOMO, INC. (DOMO) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $79.4M, roughly 1.6× DOMO, INC.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -13.1%, a 16.4% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -0.5%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $1.1M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -0.5%).
Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
DOMO vs NATR — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.4M | $123.8M |
| Net Profit | $-10.4M | $4.1M |
| Gross Margin | 74.2% | 72.5% |
| Operating Margin | -8.7% | 4.3% |
| Net Margin | -13.1% | 3.3% |
| Revenue YoY | -0.5% | 4.7% |
| Net Profit YoY | 44.6% | 1379.4% |
| EPS (diluted) | $-0.25 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.4M | $123.8M | ||
| Q3 25 | $79.7M | $128.3M | ||
| Q2 25 | $80.1M | $114.8M | ||
| Q1 25 | $78.8M | $113.2M | ||
| Q4 24 | $79.8M | $118.2M | ||
| Q3 24 | $78.4M | $114.6M | ||
| Q2 24 | $80.1M | $110.6M | ||
| Q1 24 | $80.2M | $111.0M |
| Q4 25 | $-10.4M | $4.1M | ||
| Q3 25 | $-22.9M | $5.3M | ||
| Q2 25 | $-18.1M | $5.3M | ||
| Q1 25 | $-17.7M | $4.7M | ||
| Q4 24 | $-18.8M | $-321.0K | ||
| Q3 24 | $-19.5M | $4.3M | ||
| Q2 24 | $-26.0M | $1.3M | ||
| Q1 24 | $-18.7M | $2.3M |
| Q4 25 | 74.2% | 72.5% | ||
| Q3 25 | 74.8% | 73.3% | ||
| Q2 25 | 74.2% | 71.7% | ||
| Q1 25 | 74.4% | 72.1% | ||
| Q4 24 | 75.0% | 72.0% | ||
| Q3 24 | 74.3% | 71.3% | ||
| Q2 24 | 74.1% | 71.4% | ||
| Q1 24 | 76.3% | 71.2% |
| Q4 25 | -8.7% | 4.3% | ||
| Q3 25 | -9.1% | 7.0% | ||
| Q2 25 | -17.9% | 3.7% | ||
| Q1 25 | -15.6% | 5.4% | ||
| Q4 24 | -13.9% | 3.8% | ||
| Q3 24 | -18.5% | 4.6% | ||
| Q2 24 | -26.8% | 5.1% | ||
| Q1 24 | -16.6% | 4.2% |
| Q4 25 | -13.1% | 3.3% | ||
| Q3 25 | -28.8% | 4.2% | ||
| Q2 25 | -22.5% | 4.6% | ||
| Q1 25 | -22.4% | 4.2% | ||
| Q4 24 | -23.5% | -0.3% | ||
| Q3 24 | -24.9% | 3.8% | ||
| Q2 24 | -32.5% | 1.2% | ||
| Q1 24 | -23.3% | 2.1% |
| Q4 25 | $-0.25 | $0.23 | ||
| Q3 25 | $-0.56 | $0.30 | ||
| Q2 25 | $-0.45 | $0.28 | ||
| Q1 25 | $-0.45 | $0.25 | ||
| Q4 24 | $-0.48 | $-0.02 | ||
| Q3 24 | $-0.51 | $0.23 | ||
| Q2 24 | $-0.69 | $0.07 | ||
| Q1 24 | $-0.51 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.9M |
| Total DebtLower is stronger | $124.2M | — |
| Stockholders' EquityBook value | $-191.9M | $161.6M |
| Total Assets | $201.6M | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | $47.2M | $81.3M | ||
| Q1 25 | $45.3M | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | — | $78.7M | ||
| Q2 24 | $61.2M | $68.7M | ||
| Q1 24 | $60.9M | $77.8M |
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | $2.1M |
| Q4 25 | $-191.9M | $161.6M | ||
| Q3 25 | $-191.5M | $166.7M | ||
| Q2 25 | $-178.7M | $163.7M | ||
| Q1 25 | $-177.2M | $167.1M | ||
| Q4 24 | $-171.2M | $161.0M | ||
| Q3 24 | $-166.4M | $162.6M | ||
| Q2 24 | $-163.5M | $156.4M | ||
| Q1 24 | $-153.5M | $159.7M |
| Q4 25 | $201.6M | $261.1M | ||
| Q3 25 | $195.7M | $264.8M | ||
| Q2 25 | $189.7M | $254.9M | ||
| Q1 25 | $214.3M | $252.7M | ||
| Q4 24 | $190.2M | $240.9M | ||
| Q3 24 | $197.8M | $245.3M | ||
| Q2 24 | $204.4M | $235.8M | ||
| Q1 24 | $225.7M | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $9.9M |
| Free Cash FlowOCF − Capex | $1.1M | $7.6M |
| FCF MarginFCF / Revenue | 1.4% | 6.1% |
| Capex IntensityCapex / Revenue | 2.9% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $9.9M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $9.9M | ||
| Q3 25 | $3.4M | $18.5M | ||
| Q2 25 | $4.0M | $4.3M | ||
| Q1 25 | $8.9M | $2.6M | ||
| Q4 24 | $-13.7M | $12.2M | ||
| Q3 24 | $-6.2M | $9.6M | ||
| Q2 24 | $1.9M | $1.3M | ||
| Q1 24 | $5.4M | $2.2M |
| Q4 25 | $1.1M | $7.6M | ||
| Q3 25 | $1.0M | $16.8M | ||
| Q2 25 | $1.0M | $3.0M | ||
| Q1 25 | $6.7M | $1.5M | ||
| Q4 24 | $-16.2M | $10.0M | ||
| Q3 24 | $-8.4M | $7.9M | ||
| Q2 24 | $-625.0K | $-2.0M | ||
| Q1 24 | $2.9M | $-1.5M |
| Q4 25 | 1.4% | 6.1% | ||
| Q3 25 | 1.3% | 13.1% | ||
| Q2 25 | 1.3% | 2.6% | ||
| Q1 25 | 8.5% | 1.3% | ||
| Q4 24 | -20.3% | 8.5% | ||
| Q3 24 | -10.7% | 6.9% | ||
| Q2 24 | -0.8% | -1.9% | ||
| Q1 24 | 3.6% | -1.4% |
| Q4 25 | 2.9% | 1.9% | ||
| Q3 25 | 2.9% | 1.3% | ||
| Q2 25 | 3.7% | 1.2% | ||
| Q1 25 | 2.8% | 1.0% | ||
| Q4 24 | 3.2% | 1.9% | ||
| Q3 24 | 2.8% | 1.5% | ||
| Q2 24 | 3.2% | 3.0% | ||
| Q1 24 | 3.1% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
